What to Know About the Next-Gen FIT for CRC ScreeningApril 12, 2024Gastrointestinal CancerGastroenterologyPreventive CarePatient & Survivor Care
Circulating Tumor DNA Predicts Early Treatment Response in Patients With HER2-Positive CancersApril 12, 2024Patient & Survivor CareBreast CancerGastrointestinal CancerCNS/Brain CancerGynecologic CancerGenitourinary CancerHead & Neck/Thyroid Cancers
Liquid Biopsy Has Near-Perfect Accuracy for Early Pancreatic CancerApril 11, 2024Gastrointestinal CancerPatient & Survivor CarePreventive CareGastroenterology
Repeat MCED Testing May ID Early-Stage and Unscreened CancersApril 10, 2024Preventive CareBreast CancerCNS/Brain CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersGastrointestinal Cancer
Less Than 50% of Accelerated Approvals Show Clinical BenefitApril 9, 2024Practice ManagementBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
Combo Therapy Prolongs Survival in Gastric Cancer Patients, Regardless of PD-L1 ExpressionApril 9, 2024Gastrointestinal CancerGastroenterologyPatient & Survivor Care
FDA Expands Enhertu Indication to HER2-Positive Solid TumorsApril 9, 2024Breast CancerPatient & Survivor CarePractice ManagementGastrointestinal CancerMetastatic Breast Cancer
New Quality Measure Improves Follow-Up for CRC ScreeningApril 9, 2024Preventive CareGastroenterologyGastrointestinal CancerPractice Management
Eliminating H pylori Lowers CRC Incidence, Mortality RiskApril 9, 2024Preventive CareGastroenterologyGastrointestinal Cancer
Virtual Reality Brings Relief to Hospitalized Patients With CancerApril 8, 2024Patient & Survivor CareBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
Certain Pesticides Linked With Risk for Pancreatic CancerApril 4, 2024Gastrointestinal CancerGastroenterologyPatient & Survivor CarePreventive Care
A Banned Chemical That Is Still Causing CancerApril 3, 2024Preventive CareBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
Active Surveillance for Cancer Doesn’t Increase Malpractice RiskApril 1, 2024Practice ManagementGastrointestinal CancerGenitourinary CancerBreast CancerMetastatic Breast CancerCNS/Brain CancerFollicular Lymphoma
Liquid Biopsy for Colorectal Cancer Appears Promising But Still Lacks Robust EfficacyMarch 27, 2024GastroenterologyGastrointestinal Cancer
Few Childhood Cancer Survivors Get Recommended ScreeningsMarch 25, 2024PediatricsPatient & Survivor CarePreventive CareDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
